Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stromal Cells for Sepsis and Septic Shock
NCT05283317Phase 2Completed
- Sponsor
- Erciyes University
- Start
- Mar 2018
- Primary completion
- Aug 2019
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Provacel in sepsis, septic shock, sponsored by Erciyes University. Started Mar 2018; status: completed.
02
Drugs
Provacel
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT05283317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05283317.